These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23026534)
1. Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease. Leszek J; Sochocka M; Gąsiorowski K J Neurol Sci; 2012 Dec; 323(1-2):25-32. PubMed ID: 23026534 [TBL] [Abstract][Full Text] [Related]
2. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652 [TBL] [Abstract][Full Text] [Related]
3. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. Reddy PH J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Roy S; Rauk A Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. Bennett S; Grant MM; Aldred S J Alzheimers Dis; 2009; 17(2):245-57. PubMed ID: 19221412 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: the quest to understand complexity. Marques SC; Oliveira CR; Outeiro TF; Pereira CM J Alzheimers Dis; 2010; 21(2):373-83. PubMed ID: 20555132 [TBL] [Abstract][Full Text] [Related]
10. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. de la Torre JC J Alzheimers Dis; 2012; 32(3):553-67. PubMed ID: 22842871 [TBL] [Abstract][Full Text] [Related]
11. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659 [TBL] [Abstract][Full Text] [Related]
12. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease]. Polidori MC; Stahl W; De Spirt S; Pientka L Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842 [TBL] [Abstract][Full Text] [Related]
13. Vascular and metabolic dysfunction in Alzheimer's disease: a review. Murray IV; Proza JF; Sohrabji F; Lawler JM Exp Biol Med (Maywood); 2011 Jul; 236(7):772-82. PubMed ID: 21680755 [TBL] [Abstract][Full Text] [Related]
14. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747 [TBL] [Abstract][Full Text] [Related]
16. Hypothesis on the relationship between the change in intracellular pH and incidence of sporadic Alzheimer's disease or vascular dementia. Fang B; Wang D; Huang M; Yu G; Li H Int J Neurosci; 2010 Sep; 120(9):591-5. PubMed ID: 20707633 [TBL] [Abstract][Full Text] [Related]
17. Epigenetically regulated microRNAs in Alzheimer's disease. Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656 [TBL] [Abstract][Full Text] [Related]